What to do with COVID Anger
Following news of yet another potential surge in COVID-19 cases driven by the subvariant of Omicron, many people are facing an uncomfortable feeling: anger.
Dr. Molly Colvin is Director of MGH’s Learning and Emotional Assessment Program (LEAP) and Assistant Professor of Psychology at Harvard Medical School. Dr. Colvin graduated from Wellesley College, completed a PhD in cognitive neuroscience at Dartmouth College, and completed a clinical psychology program at Suffolk University. Her clinical training included a psychology internship at MGH and a postdoctoral fellowship in clinical neuropsychology at MGH and Brigham and Women's Hospital. She is a licensed clinical psychologist in Massachusetts. She is board certified in clinical neuropsychology with subspecialty certification in pediatric neuropsychology from the American Board of Professional Psychology (ABPP).
Dr. Colvin performs neuropsychological evaluations of children and adults, specializing in pediatric-onset disorders involving medical, psychiatric, and learning concerns. She has a particular interest in pediatric-onset movement and neuromuscular disorders. Dr. Colvin's research broadly aims to understand the development of neuropsychiatric conditions and to promote healthy functioning in affected children and families. She is also actively involved in the teaching and practice of neuropsychology at the local and national level.
Clinical Interests:
Treats:
Mass General Psychiatry: Learning & Emotional Assessment Program (LEAP)
151 Merrimac St.
5th Floor
Boston, MA 02114
Phone: 617-643-6010
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Following news of yet another potential surge in COVID-19 cases driven by the subvariant of Omicron, many people are facing an uncomfortable feeling: anger.